• Celltrion
• RemsimaSC
• PharmEdaily

Remsima SC Captures 22% of European Market, 5 Fold Growth in 4 Years

• 송영두
• 2025.05.28
• 오전 10:01

• Cellid
• ABLBio
• Amicogen
• PharmEdaily

Biotech Rallies as Four Firms Join Korea’s Top 10 Stock Gainers[K-Bio Pulse]

• 유진희
• 2025.05.28
• 오전 07:48

• Pharmedaily
• Raphas
• Daewhapharm
• Cellumed

Raphas Hits Upper Limit on Progress in Obesity Patch Development…Daewha·Cellumed↑[K-bio Pulse]

• 신민준
• 2025.05.27
• 오전 07:35

• SamsungBiologics
• CMO
• Pharmedaily

Samsung Biologics Breaks $2.4B in 2025 Orders on CMO Contracts

• 김승권
• 2025.05.26
• 오전 11:30

Hair Loss, National Projects, Organoids... Soaring on Policy Tailwinds[K-BIo Pulse]

• 김지완
• 2025.05.26
• 오전 07:35

• HyundaiBioscience
• COVID-19
• Xafty

Hyundai Bioscience Initiates Global Phase 2/3 Trial of COVID-19 Treatment Xafty

• 유진희
• 2025.05.23
• 오후 02:08

• pharmedaily
• shinpoongpharm
• thebiomed
• samsungb

COVID19 and Avian Flu Resurgence Fears Send Shinpoong·Thebiomed Soaring[K-bio Pulse]

• 신민준
• 2025.05.23
• 오전 09:00

• Pharmedaily
• HuonsGlobal

Huons Global purchases HuM&C’s shares worth about 400 million won

• 신민준
• 2025.05.22
• 오후 07:06

Biosolution to Supply 3D Tissue Models for Animal Alternative Testing

• 석지헌
• 2025.05.22
• 오후 04:51

Samsung Biologics to split off biosimilar business

• 임정요
• 2025.05.22
• 오후 04:06